Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosella Ombrato

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Neurobiology of Disease|November 7, 2024
Early dysregulation of GSK3β impairs mitochondrial activity in Fragile X SyndromeGiulia Cencelli, Giorgia Pedini, Carlotta Ricci, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput ScreeningBarbara Garofalo, Federica Prati, Rosa Buonfiglio, et al.
Plos One|February 20, 2020
Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitorsNoemi D'Atanasio, Alessandra Capezzone de Joannon, Laura Di Sante, et al.
Journal of Medicinal Chemistry|October 22, 2015
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood DisordersGuido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
New anti-viral drugs for the treatment of the common coldCaterina Maugeri, Maria A Alisi, Claudia Apicella, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and <i>In Vivo</i> Activity in a Mood Disorder ModelFederica Prati, Rosa Buonfiglio, Guido Furlotti, et al.
Journal of Medicinal Chemistry|October 10, 2012
Discovery and pharmacological profile of new 1H-indazole-3-carboxamide and 2H-pyrrolo[3,4-c]quinoline derivatives as selective serotonin 4 receptor ligandsGuido Furlotti, Maria Alessandra Alisi, Claudia Apicella, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Neurobiology of Disease|November 7, 2024
Early dysregulation of GSK3β impairs mitochondrial activity in Fragile X SyndromeGiulia Cencelli, Giorgia Pedini, Carlotta Ricci, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput ScreeningBarbara Garofalo, Federica Prati, Rosa Buonfiglio, et al.
Plos One|February 20, 2020
Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitorsNoemi D'Atanasio, Alessandra Capezzone de Joannon, Laura Di Sante, et al.
Journal of Medicinal Chemistry|October 22, 2015
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood DisordersGuido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
New anti-viral drugs for the treatment of the common coldCaterina Maugeri, Maria A Alisi, Claudia Apicella, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and <i>In Vivo</i> Activity in a Mood Disorder ModelFederica Prati, Rosa Buonfiglio, Guido Furlotti, et al.
Journal of Medicinal Chemistry|October 10, 2012
Discovery and pharmacological profile of new 1H-indazole-3-carboxamide and 2H-pyrrolo[3,4-c]quinoline derivatives as selective serotonin 4 receptor ligandsGuido Furlotti, Maria Alessandra Alisi, Claudia Apicella, et al.
Pageof 2